Evidence map›Paper›PMID 37438244›Full record

ArticleDrug and alcohol dependence2023

Corrigendum to "Genetic predisposition to major depressive disorder differentially impacts alcohol consumption and high-risk drinking situations in men and women with alcohol use disorder" [Drug Alcohol Depend. 243 (2023) 109753].

Victor M Karpyak, Brandon J Coombes, Jennifer R Geske, Vanessa M Pazdernik, Terry Schneekloth, Bhanu Prakash Kolla, Tyler Oesterle, Larissa L Loukianova, Michelle K Skime, Ada Man-Choi Ho and 5 more

Open access · hybridAbstract readPublished Erratum
In one paragraph

Article in Drug and alcohol dependence, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 81% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Victor M KarpyakDepartment of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA. Electronic address: karpyak.victor@mayo.edu.
Brandon J CoombesDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Jennifer R GeskeDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Vanessa M PazdernikDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Terry SchneeklothDepartment of Psychiatry & Psychology, Mayo Clinic, Scottdale, AZ, USA.
Bhanu Prakash KollaDepartment of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA.
Tyler OesterleDepartment of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA.
Larissa L LoukianovaDepartment of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA.
Michelle K SkimeDepartment of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA.
Ada Man-Choi HoDepartment of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA.
Quyen NgoHazelden Betty Ford Foundation, Center City, MN, USA.
Cedric SkillonHazelden Betty Ford Foundation, Center City, MN, USA.
Ming-Fen HoDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.
Richard WeinshilboumDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.
Joanna M BiernackaDepartment of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Mayo Clinic · USMayo Clinic in Florida · USHazelden Betty Ford Graduate School of Addiction Studies · USWinnMed · USMayo Clinic in Arizona · US

Funding

Pharmacogenomics of Acamprosate Treatment Outcome (Supplement)U01AA027487 · NIAAA · MAYO CLINIC ROCHESTER · PI BIERNACKA, JOANNA M, KARPYAK, VICTOR M. · 2018 to 2023
$3.7M
The Mayo Clinic Center for Individualized Treatment of Alcohol DependenceP20AA017830 · NIAAA · MAYO CLINIC ROCHESTER · PI CHOI, DOO-SUP · 2009 to 2010
$2.5M
Pharmacogenomics of Treatment Outcomes in Alcohol Use DisordersR21AA025214 · NIAAA · MAYO CLINIC ROCHESTER · PI BIERNACKA, JOANNA M, KARPYAK, VICTOR M. · 2016 to 2017
$417k
NIAAA NIH HHS P20 AA017830NIAAA NIH HHS R21 AA025214NIAAA NIH HHS U01 AA027487
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37438244
PMCPMC10530382
OpenAlexW4383877470

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.